Wolfgang Miesbach on GTH Certification Program for Haemophilia Centres in German-Speaking Countries
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn:
”Quality Standards in Haemophilia Care: Five Years of Successful Center Certification
Thrilled to share our latest publication, led by Hermann Eichler, in Haemophilia Journal on the GTH certification program for haemophilia centres in German-speaking countries.
The Challenge
Specialized haemophilia centres have transformed outcomes for people with bleeding disorders, but consistent quality across centres is not a given. Building on the European EUHANET guidelines, the GTH developed its own structural and process quality guideline and launched an independent certification process in 2019.
The Methodology
Scope: Certification conceptually designed for Germany, Austria and Switzerland under the umbrella of GTH; all 23 certified centres so far are in Germany, with the first Swiss audit planned.
Centre types: Haemophilia Comprehensive Care Centres (≥40 patients with severe haemophilia A/B or vWD type 3) and Haemophilia Treatment Centres (≥10 patients).
Audit set-up: One-day on-site audit by two experienced haemophilia physicians specifically trained in quality management, supported by professional QM staff.
What was assessed: Compliance with GTH criteria on personnel, infrastructure, diagnostics, treatment (incl. surgery), registry participation and patient/relative education.
Governance: Scientific content by GTH; operational implementation and independence ensured by the accredited certification body ClarCert GmbH.
The Results
23 centres certified (2019–2024), based on 25 audits (including one repeat and one recertification).
Mean 2.8 nonconformities per audit (range 0–14), dropping to ~1.2 from 2021 onwards with better preparation and QM support.
On average 6 recommendations per centre, used to move beyond minimum standards toward continuous improvement.
Centres rated both the auditors and ClarCert as “excellent” (mean scores around 1.0–1.2 on a 1–4 scale), reflecting high trust and perceived added value rather than a purely administrative exercise.
17 Comprehensive Care Centres and 6 Treatment Centres now operate under a common, transparent quality framework.
In Germany, a valid certificate has become a prerequisite for haemophilia centres to conclude dedicated comprehensive-care contracts with health insurance bodies—linking measurable quality to funding and patient access.
The program also aligns national practice with evolving European accreditation efforts (EUHANET/European Association for Haemophilia and Allied Disorders (EAHAD)) while remaining pragmatic and scalable in daily clinical reality.”
Read the full article here.
Article: Five-Year Experience of Haemophilia Centre Certification Performed by the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research
Authors: Hermann Eichler, Hagen Bönigk, Susan Halimeh, Christina Hart, Judith Hörner, Robert Klamroth, Ralf Knöfler, Christoph Königs, Thomas Lang, Florian Langer, Wolfgang Miesbach, Johannes Oldenburg, Ramona Oral, Martin Olivieri, Christian Pfrepper, Jan Pilch, Ute Scholz, Werner Streif, Manuela Albisetti
Stay updated on all scientific advances with Hemostasis Today.
-
Jan 25, 2026, 12:42Lale Tokgözoğlu on Cardiovascular Risk Factors in Women
-
Jan 25, 2026, 12:32Dino Mehic on Bleeding Assessment Tools and QoL in BDUC
-
Jan 25, 2026, 12:17Natalie Arnold on 11 Clinical Trials That Will Shape Medicine in 2026
-
Jan 25, 2026, 11:46Luma Mahairi on What High-Functioning Teams Can Learn From The Blood System
-
Jan 24, 2026, 15:54Nicolas Nesseler on How Common and Serious is Post-Op Bleeding After Heart Transplantation
-
Jan 24, 2026, 15:43Roey Tagansky on Tu Youyou and the Rediscovery That Defeated Malaria
-
Jan 24, 2026, 15:27Mavis Agnes Kisakye on Community Impact at HFU
-
Jan 24, 2026, 15:15Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
-
Jan 24, 2026, 15:02Todd Davenport on The Impacts of Long COVID